What to expect at the BD&L Summit

Unlock the potential of a deal through optimized business development activities and transactional excellence to drive a company's competitive position in today's marketplace.

With the ROI for pharma R&D dwindling in recent years, business development and partnering opportunities have become an attractive strategy to bolster fledgling product pipelines and de-risk the development of new products. In order to ensure that every potential for unlocking the value of a transaction has been realized, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, and structure a transaction.

The BD&L Summit for Life Sciences will provide an overview of the industry’s most recent trends, and will feature the proven strategies and insights of leaders from biotech, mid-sized, and large pharmaceutical companies on successfully managing business development, M&A, strategic alliance, and licensing activities.